TIFFANY WILSON: Open Payments
NPI 1740765205 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 82 payments from 14 companies in 2025. Trend: 2023 $2,048 · 2024 $2,048 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $395 |
| ABBVIE INC. | 13 | $252 |
| Lilly USA, LLC | 12 | $203 |
| Novo Nordisk Inc | 10 | $140 |
| Phathom Pharmaceuticals, Inc. | 5 | $79 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Amgen Inc. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: AIRSUPRA, MOUNJARO, VRAYLAR, JARDIANCE, BREZTRI, Ozempic, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
